From: Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population
Medication | 80 (65%) |
---|---|
b-blocker | 59 (47.9%) |
verapamil | 4 (3.2%) |
disopyramide | 3 (2.4%) |
amiodaron | 10 (8.1%) |
diltiazem | 5 (4%) |
warfarin | 9 (7.3%) |
CEI/ARBs | 13 (10.5%) |
Statins | 13 (10.5%) |
Diuretics | 8 (6.5%) |
Digoxin | 2 (1.6%) |
Aspirin/clopidogrel | 16 (13%) |
No Medication | 43 (35%) |